(Total Views: 568)
Posted On: 08/09/2021 1:16:37 PM
Post# of 148899
Quote: from Ohm20
But that's the dilemma for big pharma, can they make a buyout offer small enough to not put their shareholders in revolt and big enough that Cytodyn's shareholders would vote yes. I don't think they can. After first approval for Cytodyn gets first approval a buyout is completely thrown out the window.
I just have to agree with this comment. I feel it is beyond the truth and it’s more likely prophetic and can’t agree more. After reading this I was trying to rapid fire my thumbs up tab like it was a video game but to no avail.
Thanks Ohm for the reassurance that we are well on our way to our own Big Pharma… I don’t see it any other way. I was considering aways the companies plan last year when the annual shareholders meeting produced the plan to become our own Pharmaceutical company. Then to trial 10 indications a year with the most life saving indications first. The beauty of this is… life saving is big money and the most revenue producing of the indications. This produces the largest results in Stock price the fastest also.
It will be like an explosion when we get our first 5 approvals and they just all happen to be major Block Busters in Revenue… mTNBC, Cancer basket trial, Covid LH’ers, Nash and HIV and then throw in the two Brazil severe/critical or better known now as Moderate/ Critical for a lucky 7. If we are opportunistic enough to realize a market for each indication in just these few indications… how can we not be over 3 digits inside of a year after completing these approvals and maybe mid 3 digits. I always believed in this SP going ballistic. Getting all of just these indications approved may take up to two years but it going to be a hell of a ride getting there!!! After the first one and a safety profile is accepted. The others will come quicker and quicker. Now that the fear of the stupid 13d slime balls is gone… we can relax and look forward to a great ride in my opinion.
Read More: https://investorshangout.com/post/newpost/605...z7341ZpfiO
But that's the dilemma for big pharma, can they make a buyout offer small enough to not put their shareholders in revolt and big enough that Cytodyn's shareholders would vote yes. I don't think they can. After first approval for Cytodyn gets first approval a buyout is completely thrown out the window.
I just have to agree with this comment. I feel it is beyond the truth and it’s more likely prophetic and can’t agree more. After reading this I was trying to rapid fire my thumbs up tab like it was a video game but to no avail.
Thanks Ohm for the reassurance that we are well on our way to our own Big Pharma… I don’t see it any other way. I was considering aways the companies plan last year when the annual shareholders meeting produced the plan to become our own Pharmaceutical company. Then to trial 10 indications a year with the most life saving indications first. The beauty of this is… life saving is big money and the most revenue producing of the indications. This produces the largest results in Stock price the fastest also.
It will be like an explosion when we get our first 5 approvals and they just all happen to be major Block Busters in Revenue… mTNBC, Cancer basket trial, Covid LH’ers, Nash and HIV and then throw in the two Brazil severe/critical or better known now as Moderate/ Critical for a lucky 7. If we are opportunistic enough to realize a market for each indication in just these few indications… how can we not be over 3 digits inside of a year after completing these approvals and maybe mid 3 digits. I always believed in this SP going ballistic. Getting all of just these indications approved may take up to two years but it going to be a hell of a ride getting there!!! After the first one and a safety profile is accepted. The others will come quicker and quicker. Now that the fear of the stupid 13d slime balls is gone… we can relax and look forward to a great ride in my opinion.
Read More: https://investorshangout.com/post/newpost/605...z7341ZpfiO
(4)
(0)Scroll down for more posts ▼
